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cantly, only 2% had mild aortic
insufficiency. Comparison of these two se-
ries is difficult because of the differences in
population and etiology, but in the absence
of prospective or randomized studies, we
must base our decisions on extrapolation
from current data. Thus there is no conclu-
sive evidence that valve-sparing operations
for patients with MFS have an advantage
relative to Freestyle root replacement. Anti-
mineralization treatment and zero-pressure
fixation8 make this valve more attractive for
implantation than a homograft because of the
lower rate of calcification with no significant
changes in the elastic properties of the elastic
wall,8,9 and reoperation if needed is simpler
with the Freestyle bioprosthesis because of
lessened inflammatory reaction in the host
tissues. A Freestyle root replacement with
graft extension could be a reasonable opera-
tion for patients with MFS for whom antico-
agulation is contraindicated or not accept-
able. Further long term data are needed,
however, before any of these operations can
be recommended with certainty.
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Amiodarone for postoperative atrial
fibrillation
To the Editor:
We read with interest the article by Yagdi
and colleagues1 dealing with the use of
amiodarone to prevent of postoperative
atrial fibrillation (AF). In this prospective,
randomized study, 77 patients (amiodarone
group) received intravenous amiodarone
during the first 48 hours after the operation
followed by declining oral dosing over a
30-day period, and 80 patients (control
group) received placebo. The authors ob-
served a statistically significant reduction
in the incidence of AF (10% in amiodarone
group vs 25% in control group) as well as
a significant reduction in the mean duration
of AF (12.8  4.8 hours in amiodarone
group vs 34.7  28.7 hours in control
group).
We recently reported similar results in a
prospective, randomized study conducted
with 200 consecutive patients undergoing
CABG.2 The treatment group received oral
amiodarone 4 hours after arrival to the in-
tensive care unit and until hospital dis-
charge. The incidence of AF was reduced
from 25% to 12%, and its duration was also
reduced.
These two prospective randomized tri-
als constitute additional evidence for the
efficacy of amiodarone in the prevention of
AF after CABG. Interestingly, although in
our series only the oral form of amiodarone
was used, the results observed were almost
identical to those reported by Yagdi and
colleagues,1 suggesting that the intrave-
nous administration of amiodarone may not
offer additional beneficial effects in pre-
venting postoperative AF. If these observa-
tions were to be confirmed in future stud-
ies, the problem of the cost-effectiveness of
the use of amiodarone in this setting, as
alluded to in the editorial by Saltman,3
would be completely resolved.
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Reply to the Editor:
There is no consensus about the optimal
dose and route of amiodarone in prophy-
laxis against atrial fibrillation after coro-
nary artery bypass grafting. In most of the
studies we cited in our article,1 intravenous
amiodarone doses ranged from 10 mg/(kg ·
d) to 20 mg/(kg · d) through 2 to 8 days.
Oral amiodarone doses ranged from 2.8 to
7.0 g through 7 to 20 days. We used rela-
tively short-term, low-dose (10 mg/[kg · d],
for 48 hours) intravenous administration,
followed by oral tapered doses at a total of
9.0 g through 30 days. We prefer a combi-
nation therapy to take the advantage of
accelerated loading time with the intrave-
nous amiodarone and to obtain the incre-
mental benefits of the oral amiodarone
during the short-term intravenous adminis-
tration.
We found that the postoperative admin-
istration of amiodarone was effective at
significantly reducing the incidence of
postoperative atrial fibrillation by 14.6%,
the duration of atrial fibrillation episodes
by 21.9 hours, and the ventricular response
rate by 20 beats/min. In addition to the
lower incidence of postoperative atrial fi-
brillation, the amiodarone group had sig-
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nificantly fewer and less severe postopera-
tive ventricular arrhythmias than did the
control group. In addition, fatal ventricular
tachyarrhythmia was not seen in the amio-
darone group, whereas 2 deaths in the con-
trol group were related to ventricular tachy-
arrhythmia. The combined intravenous and
oral amiodarone regimen used in this study
was well tolerated.
We also found that amiodarone prophy-
laxis is cost-effective even when intrave-
nous administration is used during first 48
hours. Intravenous amiodarone use did not
require additional lines or extra intensive
care unit stays. Furthermore, the amioda-
rone group had shorter hospital stays than
did the control group (6.8 days vs 7.8
days). In our protocol, the total cost of the
amiodarone was only a third the cost of a
single day of hospitalization.
Tahir Yagdi, MD
Department of Cardiovascular Surgery
Ege University Medical Faculty
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Endotoxemia and cardiac function
To the Editor:
We read with interest the article by Aydin
and colleagues1 describing the degree of
endotoxemia in patients undergoing on-
pump versus off-pump coronary artery by-
pass grafting. The authors discussed the
possible sources of endotoxin (lipopolysac-
charide) during surgery, yet the effects of
endotoxemia on cardiac function were
mentioned only briefly.
Despite the similarity in outcomes be-
tween patients who underwent cardiopul-
monary bypass and those who did not, we
would like to point out that whereas en-
dotoxemia is usually thought to increase
cardiac output as a result of decreased
systemic vascular resistance, it may ac-
tually have a significant negative inotro-
pic effect. In cardiac surgical patients the
combination of ischemia-reperfusion in-
jury and myocardial endotoxin-mediated
stress probably has a potent effect on myo-
cardial function. The most commonly cited
mechanism for this involves vascular as well
as myocardial nitric oxide synthesis and takes
several hours to reach functional relevance
by disturbing intracellular calcium regulation
and blunting contractile protein calcium sen-
sitivity.2
Recently, we described an alternative
mechanism that brings about lipopolysac-
charide-induced negative inotropy within
minutes. Cardiomyocytes were found to
rapidly incorporate endotoxin, which acti-
vated the sphingomyelin-sphingosine sig-
naling cascade through the release of tumor
necrosis factor  and direct, paracrine mem-
brane receptor activation.3,4 Sphingosine di-
rectly inhibits calcium release from the sar-
coplasmic reticulum, thereby reducing the
amplitude of the calcium ionic transient and
impairing systolic force generation. It is im-
portant to note that all the necessary signaling
steps for cytokine-mediated negative inot-
ropy in response to endotoxin stress can oc-
cur within the myocardium, without involve-
ment of circulating cytokines. Studies that
compare the inflammatory response to off-
pump and on-pump surgery by measuring
cytokine concentrations in blood often pro-
vide conflicting results, and the discrepancy
between cytokine levels and outcome may be
attributable to the lack of direct endotoxin
measurements. The article by Aydin and col-
leagues1 fills that gap.
Cardiac index, as measured by Aydin
and colleagues,1 is dependent on preload
and afterload and therefore does not neces-
sarily reflect the actual myocardial contrac-
tility. The increased lactate concentration,
in part attributed to inhibition of pyruvate
dehydrogenase, may also be interpreted as
evidence for a compromised hemodynamic
situation resulting from primarily impaired
cardiac function. In this context, a more
detailed, load-independent analysis of
myocardial contractility might help to clar-
ify the functional relevance of endotox-
emia.
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Ascending aorta cannulation in type
A dissection
To the Editor:
The Hannover group’s approach to cannu-
lation of the ascending aorta in the setting
of type A dissection,1 although potentially
controversial, has clearly been successful
and introduces an unconventional tech-
nique in a complex situation. I have used
the same technique in 3 cases and also
found it safe. I would suggest two addi-
tional maneuvers to enhance success. First,
epiaortic echography is perhaps more pre-
cise in assessing the ideal site for cannulation
of the aorta. Second, to be sure I am in the
true lumen, I use a Seldinger technique. The
USCI cannula (US Catheter and Instrument
Co) can be placed over a wire previously
passed into the aorta over a large bore needle.
Precise positioning of the wire in the distal
arch and descending aorta with transesopha-
geal echocardiography ensures its accurate
placement. The cannula is subsequently
passed over the wire.
Alex Zapolanski, MD
San Francisco Heart Institute
Daly City, CA 94105
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